A groundbreaking trial for a prostate cancer treatment with fewer side effects has launched in the UK, researchers have said.

Backed by the Government-funded National Institute for Health and Care Research (NIHR), the trial will examine whether Aquablation – a therapy using robotics, AI and real-time imaging – works as well or better than traditional surgery, known as radical prostatectomy.

With radical prostatectomy, the entire prostate gland is removed in a bid to cure men of prostate cancer.

The treatment is suitable for men whose cancer has not spread outside of the prostate gland or has spread to the area just outside the gland.

However, the operation carries a risk of serious side effects, such as infection, erectile dysfunction and urinary problems.

With Aquablation, experts

See Full Page